BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/12/2014 8:41:00 PM | Browse: 1055 | Download: 783
Publication Name World Journal of Gastroenterology
Manuscript ID 3384
Country/Territory Italy
Received
2013-04-26 08:52
Peer-Review Started
2013-04-26 20:10
To Make the First Decision
2013-06-09 10:04
Return for Revision
2013-06-20 19:08
Revised
2013-07-10 00:28
Second Decision
2013-07-18 17:31
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-07-19 01:20
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2013-08-29 18:40
Publish the Manuscript Online
2013-09-14 11:17
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Transplantation
Manuscript Type Autobiography
Article Title Doxorubicin-eluting bead vs conventional transcatheter arterial chemoembolization for hepatocellular carcinoma before liver transplantation
Manuscript Source Invited Manuscript
All Author List Daniele Nicolini, Gianluca Svegliati-Baroni, Roberto Candelari, Cinzia Mincarelli, Alessandra Mandolesi, Italo Bearzi, Federico Mocchegiani, Andrea Vecchi, Roberto Montalti, Antonio Benedetti, Andrea Risaliti and Marco Vivarelli
Funding Agency and Grant Number
Corresponding Author Daniele Nicolini, MD, Division of Hepatobiliary and Transplant Surgery, Department of Gastroenterology and Transplantation, Polytechnic University of Marche, Ospedali Riuniti, via Conca n° 71, 60129 Ancona, Italy. nicolini_daniele@yahoo.it
Key Words Liver transplantation; Hepatocellular carcinoma; Transcatheter arterial chemoembolization; Doxorubicin-eluting bead; Tumor histology; Recurrence-free survival; Locoregional therapies
Core Tip The manuscript reports the experience with a newer technique of transcatheter arterial chemoembolization (TACE) that uses doxorubicin-eluting beads (DEB) for the treatment of hepatocellular carcinoma in liver transplant candidates. The results of DEB-TACE were compared to those of conventional TACE, and remarkably, a significantly higher recurrence-free survival after liver transplantation was observed in patients who were treated with DEB-TACE. The histological pattern observed in the area surrounding the tumor nodules of DEB-TACE patients was characterized by an intense inflammatory and fibrotic reaction, which could play a role in limiting tumor spread during waiting list time.
Publish Date 2013-09-14 11:17
Citation Nicolini D, Svegliati-Baroni G, Candelari R, Mincarelli C, Mandolesi A, Bearzi I, Mocchegiani F, Vecchi A, Montalti R, Benedetti A, Risaliti A, Vivarelli M. Doxorubicin-eluting bead vs conventional transcatheter arterial chemoembolization for hepatocellular carcinoma before liver transplantation. World J Gastroenterol 2013; 19(34): 5622-5632
URL http://www.wjgnet.com/1007-9327/full/v19/i34/5622.htm
DOI http://dx.doi.org/10.3748/wjg.v19.i34.5622
Full Article (PDF) WJG-19-5622.pdf
Manuscript File 3384-Review.docx
Answering Reviewers 3384-Answering reviewers.pdf
Copyright License Agreement 3384-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate EDITORIAL CERTIFICATE by American Journal Experts.pdf
Peer-review Report 3384-Peer review(s).docx
Scientific Editor Work List 3384-Scientific editor work list.doc